Bicycle Therapeutics PLC
NASDAQ:BCYC

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
NASDAQ:BCYC
Watchlist
Price: 23.14 USD -0.34% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Bicycle Therapeutics PLC?
Write Note

Bicycle Therapeutics PLC
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bicycle Therapeutics PLC
Accumulated Depreciation Peer Comparison

Comparables:
CNTA
EXAI
AUTL
IMCR
GNS

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
Bicycle Therapeutics PLC
NASDAQ:BCYC
Accumulated Depreciation
-$19.7m
CAGR 3-Years
-61%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Accumulated Depreciation
-$462k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Accumulated Depreciation
-ÂŁ20.7m
CAGR 3-Years
-108%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Accumulated Depreciation
-$28.8m
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Accumulated Depreciation
-ÂŁ52.3m
CAGR 3-Years
-23%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Bicycle Therapeutics PLC's Accumulated Depreciation?
Accumulated Depreciation
-19.7m USD

Based on the financial report for Sep 30, 2024, Bicycle Therapeutics PLC's Accumulated Depreciation amounts to -19.7m USD.

What is Bicycle Therapeutics PLC's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 5Y
-54%

Over the last year, the Accumulated Depreciation growth was -73%. The average annual Accumulated Depreciation growth rates for Bicycle Therapeutics PLC have been -61% over the past three years , -54% over the past five years .

Back to Top